Norway
· Delayed Price · Currency is NOK Lytix Biopharma AS Statistics
Total Valuation
OSL:LYTIX has a market cap or net worth of NOK 667.60 million. The enterprise value is 552.58 million.
| Market Cap | 667.60M |
| Enterprise Value | 552.58M |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
OSL:LYTIX has 68.26 million shares outstanding.
| Current Share Class | 68.26M |
| Shares Outstanding | 68.26M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.27% |
| Owned by Institutions (%) | 13.41% |
| Float | 31.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,098.03 |
| PB Ratio | 7.01 |
| P/TBV Ratio | 7.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.21 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.03.
| Current Ratio | 3.86 |
| Quick Ratio | 3.86 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -719.44 |
Financial Efficiency
Return on equity (ROE) is -138.05% and return on invested capital (ROIC) is -85.80%.
| Return on Equity (ROE) | -138.05% |
| Return on Assets (ROA) | -64.60% |
| Return on Invested Capital (ROIC) | -85.80% |
| Return on Capital Employed (ROCE) | -93.32% |
| Revenue Per Employee | 76,000 |
| Profits Per Employee | -11.13M |
| Employee Count | 8 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.11% in the last 52 weeks. The beta is -0.37, so OSL:LYTIX's price volatility has been lower than the market average.
| Beta (5Y) | -0.37 |
| 52-Week Price Change | -1.11% |
| 50-Day Moving Average | 7.41 |
| 200-Day Moving Average | 6.45 |
| Relative Strength Index (RSI) | 53.65 |
| Average Volume (20 Days) | 102,653 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OSL:LYTIX had revenue of NOK 608,000 and -89.01 million in losses.
| Revenue | 608,000 |
| Gross Profit | 608,000 |
| Operating Income | -90.65M |
| Pretax Income | -89.01M |
| Net Income | -89.01M |
| EBITDA | -90.58M |
| EBIT | -90.65M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 117.90 million in cash and 2.88 million in debt, giving a net cash position of 115.02 million or 1.69 per share.
| Cash & Cash Equivalents | 117.90M |
| Total Debt | 2.88M |
| Net Cash | 115.02M |
| Net Cash Per Share | 1.69 |
| Equity (Book Value) | 95.17M |
| Book Value Per Share | n/a |
| Working Capital | 94.30M |
Cash Flow
| Operating Cash Flow | -58.93M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -14,909.54% |
| Pretax Margin | -14,638.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OSL:LYTIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -13.33% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |